GammaTile

August 14, 2017October 24, 2017

Cesium-131 Brachytherapy May Be Prostate Cancer Game-changer, Study Reports

News

About 161,360 new cases of prostate cancer will be diagnosed in the United States in 2017, according to the American Cancer Society. The usual treatment options are radiation or surgery, both of ... Read more

July 12, 2017

FDA Requests More Data After Reviewing IsoRay’s Application for GammaTile Radiation Therapy

News

IsoRay, a company specializing in the treatment of prostate and other cancers, has received a response from the U.S. Food and Drug Administration (FDA) regarding the company’s pending 510(k) application ... Read more